Could simple supplements ease a rare lung disease? new trial aims to find out
NCT ID NCT06959251
First seen Dec 08, 2025 · Last updated May 16, 2026 · Updated 18 times
Summary
This study tests whether daily supplements of glycine (an amino acid) and magnesium plus thiamine (vitamin B1) can reduce lung infections and improve breathing and quality of life in people with primary ciliary dyskinesia (PCD), a rare condition that makes it hard to clear mucus from the airways. About 60 participants aged 5 and older will take one of three supplement combinations or a placebo for 6 months. The goal is to see if these supplements, which are already safe for general use, can offer a new way to manage PCD symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CILIARY DYSKINESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto Nacional de Enfermedades Respiratorias
RECRUITINGMexico City, 14080, Mexico
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.